Logo image of JBGS

JBG SMITH PROPERTIES (JBGS) Stock Fundamental Analysis

NYSE:JBGS - New York Stock Exchange, Inc. - US46590V1008 - REIT - Currency: USD

14.96  -0.18 (-1.19%)

Fundamental Rating

2

Taking everything into account, JBGS scores 2 out of 10 in our fundamental rating. JBGS was compared to 129 industry peers in the Diversified REITs industry. JBGS may be in some trouble as it scores bad on both profitability and health. JBGS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year JBGS has reported negative net income.
JBGS had a positive operating cash flow in the past year.
JBGS had negative earnings in 4 of the past 5 years.
In the past 5 years JBGS always reported a positive cash flow from operatings.
JBGS Yearly Net Income VS EBIT VS OCF VS FCFJBGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

With a Return On Assets value of -2.91%, JBGS is not doing good in the industry: 77.52% of the companies in the same industry are doing better.
The Return On Equity of JBGS (-8.07%) is worse than 75.19% of its industry peers.
JBGS's Return On Invested Capital of 0.11% is on the low side compared to the rest of the industry. JBGS is outperformed by 88.37% of its industry peers.
The Average Return On Invested Capital over the past 3 years for JBGS is below the industry average of 3.17%.
Industry RankSector Rank
ROA -2.91%
ROE -8.07%
ROIC 0.11%
ROA(3y)-0.99%
ROA(5y)-1.07%
ROE(3y)-2.88%
ROE(5y)-2.7%
ROIC(3y)0.37%
ROIC(5y)N/A
JBGS Yearly ROA, ROE, ROICJBGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4 -6 -8

1.3 Margins

The Operating Margin of JBGS (1.25%) is worse than 88.37% of its industry peers.
JBGS's Operating Margin has declined in the last couple of years.
JBGS has a Gross Margin of 50.03%. This is in the lower half of the industry: JBGS underperforms 77.52% of its industry peers.
JBGS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.25%
PM (TTM) N/A
GM 50.03%
OM growth 3YN/A
OM growth 5Y-29.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5Y-0.13%
JBGS Yearly Profit, Operating, Gross MarginsJBGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so JBGS is destroying value.
The number of shares outstanding for JBGS has been reduced compared to 1 year ago.
The number of shares outstanding for JBGS has been reduced compared to 5 years ago.
JBGS has a worse debt/assets ratio than last year.
JBGS Yearly Shares OutstandingJBGS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
JBGS Yearly Total Debt VS Total AssetsJBGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

JBGS has an Altman-Z score of 0.08. This is a bad value and indicates that JBGS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.08, JBGS is not doing good in the industry: 72.09% of the companies in the same industry are doing better.
JBGS has a Debt/Equity ratio of 1.42. This is a high value indicating a heavy dependency on external financing.
JBGS has a Debt to Equity ratio (1.42) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Altman-Z 0.08
ROIC/WACC0.02
WACC6.6%
JBGS Yearly LT Debt VS Equity VS FCFJBGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

JBGS has a Current Ratio of 1.95. This is a normal value and indicates that JBGS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.95, JBGS is doing good in the industry, outperforming 77.52% of the companies in the same industry.
JBGS has a Quick Ratio of 1.95. This is a normal value and indicates that JBGS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of JBGS (1.95) is better than 77.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.95
JBGS Yearly Current Assets VS Current LiabilitesJBGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

1

3. Growth

3.1 Past

JBGS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.23%.
Looking at the last year, JBGS shows a decrease in Revenue. The Revenue has decreased by -9.42% in the last year.
The Revenue has been decreasing by -3.32% on average over the past years.
EPS 1Y (TTM)-23.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%156.25%
Revenue 1Y (TTM)-9.42%
Revenue growth 3Y-4.8%
Revenue growth 5Y-3.32%
Sales Q2Q%-17.23%

3.2 Future

The Earnings Per Share is expected to decrease by -13.91% on average over the next years. This is quite bad
Based on estimates for the next years, JBGS will show a decrease in Revenue. The Revenue will decrease by -2.07% on average per year.
EPS Next Y-31.14%
EPS Next 2Y-13.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.02%
Revenue Next 2Y-2.07%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JBGS Yearly Revenue VS EstimatesJBGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
JBGS Yearly EPS VS EstimatesJBGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JBGS. In the last year negative earnings were reported.
Also next year JBGS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBGS Price Earnings VS Forward Price EarningsJBGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JBGS indicates a slightly more expensive valuation: JBGS is more expensive than 65.89% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.91
JBGS Per share dataJBGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

JBGS's earnings are expected to decrease with -13.91% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.91%
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

JBGS has a Yearly Dividend Yield of 4.62%, which is a nice return.
Compared to an average industry Dividend Yield of 6.65, JBGS has a dividend in line with its industry peers.
JBGS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 4.62%

5.2 History

The dividend of JBGS decreases each year by -7.39%.
JBGS has been paying a dividend for over 5 years, so it has already some track record.
The dividend of JBGS decreased recently.
Dividend Growth(5Y)-7.39%
Div Incr Years1
Div Non Decr Years1
JBGS Yearly Dividends per shareJBGS Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

JBGS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
JBGS's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-42.47%
EPS Next 2Y-13.91%
EPS Next 3YN/A
JBGS Yearly Income VS Free CF VS DividendJBGS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M

More info and screens

JBG SMITH PROPERTIES

NYSE:JBGS (5/5/2025, 3:26:57 PM)

14.96

-0.18 (-1.19%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-28 2025-07-28
Inst Owners96.23%
Inst Owner Change-0.03%
Ins Owners0.05%
Ins Owner Change1.19%
Market Cap1.09B
Analysts42.5
Price Target15.3 (2.27%)
Short Float %13.92%
Short Ratio9.59
Dividend
Industry RankSector Rank
Dividend Yield 4.62%
Yearly Dividend0.69
Dividend Growth(5Y)-7.39%
DP-42.47%
Div Incr Years1
Div Non Decr Years1
Ex-Date05-08 2025-05-08 (0.175)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-37.7%
Min EPS beat(2)-85.76%
Max EPS beat(2)10.36%
EPS beat(4)3
Avg EPS beat(4)1.94%
Min EPS beat(4)-85.76%
Max EPS beat(4)47.71%
EPS beat(8)5
Avg EPS beat(8)3.83%
EPS beat(12)7
Avg EPS beat(12)107.87%
EPS beat(16)10
Avg EPS beat(16)79.24%
Revenue beat(2)0
Avg Revenue beat(2)-16.77%
Min Revenue beat(2)-17.51%
Max Revenue beat(2)-16.03%
Revenue beat(4)0
Avg Revenue beat(4)-13.34%
Min Revenue beat(4)-18.62%
Max Revenue beat(4)-1.2%
Revenue beat(8)1
Avg Revenue beat(8)-9.48%
Revenue beat(12)1
Avg Revenue beat(12)-8.17%
Revenue beat(16)3
Avg Revenue beat(16)-3.03%
PT rev (1m)-6.25%
PT rev (3m)-3.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-15.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.44%
Revenue NY rev (3m)-3.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2
P/FCF N/A
P/OCF 8.45
P/B 0.6
P/tB 0.62
EV/EBITDA 15.91
EPS(TTM)-1.22
EYN/A
EPS(NY)-1.91
Fwd EYN/A
FCF(TTM)-1.21
FCFYN/A
OCF(TTM)1.77
OCFY11.84%
SpS7.49
BVpS24.76
TBVpS24.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.91%
ROE -8.07%
ROCE 0.14%
ROIC 0.11%
ROICexc 0.12%
ROICexgc 0.12%
OM 1.25%
PM (TTM) N/A
GM 50.03%
FCFM N/A
ROA(3y)-0.99%
ROA(5y)-1.07%
ROE(3y)-2.88%
ROE(5y)-2.7%
ROIC(3y)0.37%
ROIC(5y)N/A
ROICexc(3y)0.39%
ROICexc(5y)N/A
ROICexgc(3y)0.4%
ROICexgc(5y)N/A
ROCE(3y)0.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-29%
ROICexc growth 3YN/A
ROICexc growth 5Y-29.03%
OM growth 3YN/A
OM growth 5Y-29.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5Y-0.13%
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Debt/EBITDA 11.58
Cap/Depr 101.41%
Cap/Sales 39.84%
Interest Coverage 0.06
Cash Conversion 58.32%
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.95
Altman-Z 0.08
F-Score4
WACC6.6%
ROIC/WACC0.02
Cap/Depr(3y)148.41%
Cap/Depr(5y)152.09%
Cap/Sales(3y)54.34%
Cap/Sales(5y)56.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%156.25%
EPS Next Y-31.14%
EPS Next 2Y-13.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.42%
Revenue growth 3Y-4.8%
Revenue growth 5Y-3.32%
Sales Q2Q%-17.23%
Revenue Next Year-5.02%
Revenue Next 2Y-2.07%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-85.68%
EBIT growth 3YN/A
EBIT growth 5Y-31.53%
EBIT Next Year2599.06%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29.44%
OCF growth 3Y-15.91%
OCF growth 5Y-5.75%